Article Text

PDF
NIH Names CSR Acting Director

Statistics from Altmetric.com

Richard Nakamura, PhD, has been named Acting Director of the Center for Scientific Review (CSR) at the National Institutes of Health (NIH). He succeeds CSR Director Toni Scarpa, MD, PhD. Dr.Scarpa, who served as CSR Director for six years, announced his retirement in July. Dr. Nakamura has served at the National Institute of Mental Health (NIMH), of the NIH, for 35 years, where he served as Scientific Director and Deputy Director and, from 2001 to 2002, as Acting Director. In his new post, he will oversee incoming NIH grant applications management.

Dr. Nakamura earned his MA in psychology from New York University and completed his PhD in psychology at the State University of New York at Stony Brook. He joined the NIMH as a postdoctoral fellow in 1976. During his tenure at NIMH, he held numerous leadership roles, including: Associate Director for Science Policy and Program Planning; Chief, Behavioral and Integrative Neuroscience Research Branch; and Coordinator, Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) Office of Animal Research Issues. He has received numerous honors for his leadership and service, including the Presidential Rank Award for outstanding leadership as well as awards from the Federation of Behavioral Psychological and Cognitive Sciences and from the International Society for Behavioral Neuroscience. He is an elected Fellow of the American Association for the Advancement of Science (AAAS).

GHSU Appoints Director of Cancer Center

Samir N. Khleif, MD Courtesy Georgia Health Sciences University

Samir N. Khleif, MD, Chief of the National Institutes of Health (NIH) National Cancer Institute’s (NCI) Cancer Vaccine Section, has been named Director of the Georgia Health Sciences University (GHSU) Cancer Center. In his new post, Dr. Khleif will oversee cancer clinical care and research at GHSU.

Dr. Khleif’s research has included pioneering cancer vaccine clinical trials aimed at targeting specific genetic changes in cancer cells. He joined …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.